The Food and Drug Administration (FDA) has approved a new presentation of Selarsdi ™ (ustekinumab-aekn), a biosimilar to Stelara ® (ustekinumab), expanding the product’s indications to include ...
In the world of nuclear medicine, health care professionals face the challenge of safeguarding themselves and their patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback